Related Experiment Video
Updated: Aug 19, 2026

Amikacin Protection Assay for Quantification and Visualization of Escherichia coli Cell Invasion
Published on: July 3, 2026
Strong decrease in invasive ability and outer membrane vesicle release in Crohn's disease-associated
Nathalie Rolhion1, Nicolas Barnich, Laurent Claret
1Pathogénie Bactérienne Intestinale, Laboratoire de Bactériologie, Université d'Auvergne, CBRV, 28 Place Henri Dunant, 63001 Clermont-Ferrand, France.
Abstract:
Adherent-invasive Escherichia coli strain LF82 recovered from a chronic lesion of a patient with Crohn's disease is able to invade cultured intestinal epithelial cells. Three mutants with impaired ability to invade epithelial cells had the Tn5phoA transposon inserted in the yfgL gene encoding the YfgL lipoprotein. A yfgL- negative isogenic mutant showed a marked decrease both in its ability to invade Intestine-407 cells and in the amount of the outer membrane proteins OmpA and OmpC in the culture supernatant, as shown by analysis of the culture supernatant protein contents by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and matrix-assisted laser desorption ionization-time of flight mass spectrometry. Transcomplementation of the LF82-DeltayfgL isogenic mutant with the cloned yfgL gene restored invasion ability and outer membrane protein release in the culture supernatant. The outer membrane proteins in the culture supernatant of strain LF82 resulted from the formation of vesicles. This was shown by Western blot analysis of periplasmic and outer membrane fraction markers typically found in outer membrane vesicles and by transmission electron microscopic analysis of ultracentrifuged cell-free LF82 supernatant pellets, indicating the presence of vesicles with a bilayered structure surrounding a central electron-dense core. Thus, deletion of the yfgL gene in strain LF82 resulted in a decreased ability to invade intestinal epithelial cells and a decreased release of outer membrane vesicles.
Insights
Adherent-invasive Escherichia coli uses YfgL protein to release outer membrane vesicles, which are crucial for invading intestinal cells. Deleting yfgL impairs this invasion process in Crohn's disease models.
Area of Science:
- Microbiology
- Molecular Biology
- Cell Biology
Background:
- Adherent-invasive Escherichia coli (AIEC) strain LF82, isolated from Crohn's disease patients, invades intestinal epithelial cells.
- Outer membrane vesicles (OMVs) are implicated in bacterial pathogenesis and host-pathogen interactions.
Purpose of the Study:
- To investigate the role of the yfgL gene and its encoded lipoprotein (YfgL) in AIEC LF82's ability to invade intestinal epithelial cells.
- To determine the impact of yfgL deletion on the production and release of outer membrane proteins and vesicles.
Main Methods:
- Genetic manipulation to create yfgL-negative isogenic mutants of AIEC LF82.
- Invasion assays using Intestine-407 cell cultures.
- Analysis of outer membrane proteins in culture supernatants using SDS-PAGE and MALDI-TOF MS.
- Western blot analysis and transmission electron microscopy (TEM) to characterize outer membrane vesicles.
Main Results:
- Deletion of the yfgL gene significantly reduced the invasion ability of AIEC LF82.
- The yfgL mutant showed decreased release of outer membrane proteins (OmpA, OmpC) into the supernatant.
- Characterization confirmed that released proteins were part of outer membrane vesicles, and yfgL deletion decreased OMV release.
- Complementation with the yfgL gene restored both invasion ability and OMV release.
Conclusions:
- The YfgL lipoprotein plays a critical role in the biogenesis or release of outer membrane vesicles in AIEC LF82.
- Reduced OMV release due to yfgL deletion directly correlates with impaired intestinal epithelial cell invasion.
- Targeting YfgL or OMV production may represent a novel therapeutic strategy against AIEC infections in Crohn's disease.
Related Concept Videos
Bacterial Gastroenteritis
Stringent Response in E. coli
Inflammatory Bowel Disease III: Crohn's Disease
